COMMUNIQUÉS West-GlobeNewswire

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
13/08/2026
- Q2 net ZEVASKYN® revenue increased 31% quarter-over-quarter to $11.4 million – - Five patients treated with ZEVASKYN in Q2 2026 and three treatments in Q3 2026 to-date; since launch, 12 treatments completed – - [...]
Collegium Announces $50 Million Accelerated Share Repurchase Program
13/08/2026
STOUGHTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood [...]
NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates
13/08/2026
Site activation and screening for the Phase 3 RESTORE study is expected to begin in September 2026, with the first participant anticipated to be dosed shortly thereafter. Strengthened leadership team, appointing Keith [...]
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
13/08/2026
‒ Q2 2026 Consolidated Revenue of $101.9 million ‒ ‒ Q2 2026 Net Income of $26.0 million ; Adjusted EBITDA of $58.7 million ‒ ‒ Company Maintains FY 2026 Revenue and Raises Adjusted EBITDA Guidance ‒ ‒ Conference Call [...]
Ascendis Pharma Reports Second Quarter 2026 Financial Results
13/08/2026
– Q2 2026 product revenue of €315 million (+105% Y/Y), comprising €252 million for YORVIPATH ® , €55 million for SKYTROFA ® , and €8 million for YUVIWEL ® – Through July 31, more than 220 unique YUVIWEL patient [...]
MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA
13/08/2026
Q2 2026 Adjusted EBITDA 1 of $0.9M, the Company’s strongest quarterly performance since 2019 2 Positive net income in Q2 2026, compared with a net loss of $3.8M in Q2 2025 OPEX decreased 44% in Q2 2026 versus Q2 2025 [...]
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
13/08/2026
FULLERTON, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”), a biopharmaceutical company developing novel therapies for cancer and other serious diseases, [...]
Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
13/08/2026
Site Activation Initiated for Confirmatory Phase 3 Study of Iopofosine I 131 with New Drug Application Submission Planned for mid-2027 under the FDA’s Accelerated Approval Program Presented Data from CLOVER WaM Trial of [...]
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
13/08/2026
Zelsuvmi ® net product revenue grew 45% to $15.4 million during the second quarter of 2026 from $10.7 million in the first quarter of 2026 11,925 Zelsuvmi units were dispensed by 4,571 unique prescribers during the [...]
Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance
13/08/2026
Second Quarter Revenue was $670.5 million, a 13.7% increase over the prior year period Second Quarter Net income was $40.3 million compared to $27.0 million for the prior year period Adjusted EBITDA for Q2 2026 was $95. [...]
Montauk Brewing Company Announces New Collaboration with Morning Brew Inc.
13/08/2026
The Morning Brew, a Blonde Ale featuring Roasted Coffee Beans, is on tap now MONTAUK, N.Y., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Montauk Brewing Company , the coastal lifestyle brand by Tilray Brands, Inc. (NASDAQ: TLRY [...]
Vireo Growth Inc. Announces Share Buyback Program
13/08/2026
MINNEAPOLIS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), a leading vertically integrated cannabis company and agricultural markets platform, today announced [...]
ApolloMD Names Brianna Watson 2026 Emergency Medicine Scholarship Winner
13/08/2026
Howard University medical student receives $5,000 award for essay on technology, environmental health and emergency medicine ATLANTA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- ApolloMD has named Brianna Watson, a fourth-year [...]
Zelluna ASA: Invitation to Second Quarter 2026 Results Webcast Presentation
13/08/2026
Oslo, Norway, 13 August 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation [...]
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
13/08/2026
SYMON-II pivotal clinical study completes targeted enrollment of 750 patients Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk [...]
Vistin Pharma ASA: Invitation to Q2 2026 conference call
13/08/2026
Oslo, Norway, 13 August 2026 Vistin Pharma ASA (VISTN) will release its second quarter and YTD 2026 results on Thursday 20th of August 2026. Vistin Pharma will host a conference call for all shareholders and other [...]
ProQR Announces Second Quarter 2026 Operating and Financial Results
13/08/2026
First clinical validation of Axiomer™ RNA editing established through NTCP modulation with positive AX-0810 clinical target engagement data; full Phase 1 dataset to be presented at a medical or scientific conference [...]
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
13/08/2026
Advanced zolucatetide across multiple Wnt/β-catenin-driven diseases, including progress toward planned Phase 3 registrational trial in desmoid tumors Announced strategic research collaboration with Regeneron to develop [...]
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
13/08/2026
• Initiated Study to Assess the Potential Impact of the Combination of Icovamenib and Low-Dose Semaglutide on Physical Function, Body Weight, Body Composition, Muscle Health, and Metabolic Outcomes SAN CARLOS, Calif., [...]

Pages